These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1241259)

  • 1. [Farnesol and neuroleptics. II. Action of farnesol, alone or associated with a neuroleptic, on the stereotypies induced in the rat by amphetamine].
    Binet P; Miocque M; Roux M; Rinjard P
    Ann Pharm Fr; 1975; 33(6-7):321-8. PubMed ID: 1241259
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of certain drugs on amphetamine-induced stereotyped behavior and brain amphetamine levels in the rat.
    Lal S; Missala K; Sourkes TL; Feldmuller F
    Biol Psychiatry; 1974 Aug; 9(1):3-10. PubMed ID: 4156181
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
    Randrup A
    Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of neuroleptic drugs on mouse jumping induced by L-DOPA in amphetamine treated mice.
    Lal H; Marky M; Fielding S
    Neuropharmacology; 1976 Nov; 15(11):669-71. PubMed ID: 1034243
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptics attentuate stereotyped behavior induced by beta-phenylethylamine in rats.
    Moja EA; Stoff DM; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1978 Apr; 13(2):291-5. PubMed ID: 566570
    [No Abstract]   [Full Text] [Related]  

  • 6. [Farnesol and neuroleptics. I. Reinforcement by farnesol of the experimental cataleptigenic effect of neuroleptics].
    Binet P; Miocque M; Roux M; Rinjard P
    Ann Pharm Fr; 1975 May; 33(5):229-34. PubMed ID: 1239975
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of neuroleptics, midantan and DOPA on apomorphine sterotypy in rats].
    Kalinin VV
    Farmakol Toksikol; 1977; 40(1):16-9. PubMed ID: 558110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system.
    Muller P; Seeman P
    J Pharm Pharmacol; 1974 Dec; 26(12):981-4. PubMed ID: 4156868
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
    Lemberger L; Kellams JJ; Small JG; Rowe H
    Commun Psychopharmacol; 1977; 1(5):501-7. PubMed ID: 564259
    [No Abstract]   [Full Text] [Related]  

  • 10. The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
    Kostowski W; Czlonkowski A
    Pharmacology; 1973; 10(2):82-7. PubMed ID: 4797045
    [No Abstract]   [Full Text] [Related]  

  • 11. MJ 9022: correlation between neuroleptic potential and stereotypy.
    Sathananthan GL; Sanghvi I; Phillips N; Gershon S
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):701-5. PubMed ID: 1208
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between neuroleptic-induced suppression of stereotyped behaviour and HVA concentrations in rat brain.
    Rollema H; Westerink BH; Grol CJ
    J Pharm Pharmacol; 1976 Apr; 28(4):321-3. PubMed ID: 6728
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral sensitization to amphetamine in rats: changes in the rhythm of head movements during focused stereotypies.
    Fowler SC; Birkestrand B; Chen R; Vorontsova E; Zarcone T
    Psychopharmacology (Berl); 2003 Nov; 170(2):167-77. PubMed ID: 12827349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and physiology of stereotyped behavior.
    Randrup A; Munkvad I
    J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. A hypothesis on their mode of interaction with the central dopamine receptor.
    Humber LG; Bruderlein FT; Voith K
    Mol Pharmacol; 1975 Nov; 11(6):833-40. PubMed ID: 1239657
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanism of action of psychopharmacological agents on behaviour.
    Munkvad I
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 2):21-30. PubMed ID: 805510
    [No Abstract]   [Full Text] [Related]  

  • 19. Modification of apomorphine induced stereotypies in rates by aversive conditioning.
    Gale KN; Murray JP; Horita A
    Proc West Pharmacol Soc; 1975; 18():375-9. PubMed ID: 1237143
    [No Abstract]   [Full Text] [Related]  

  • 20. Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances.
    Sikiric P; Jelovac N; Jelovac-Gjeldum A; Dodig G; Staresinic M; Anic T; Zoricic I; Rak D; Perovic D; Aralica G; Buljat G; Prkacin I; Lovric-Bencic M; Separovic J; Seiwerth S; Rucman R; Petek M; Turkovic B; Ziger T; Boban-Blagaic A; Bedekovic V; Tonkic A; Babic S
    Acta Pharmacol Sin; 2002 May; 23(5):412-22. PubMed ID: 11978191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.